T. Rowe Price Associates’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9M | Sell |
261,383
-149,478
| -36% | -$20.5M | ﹤0.01% | 819 |
|
|
2025
Q1 | $74.1M | Sell |
410,861
-98,598
| -19% | -$17.8M | 0.01% | 612 |
|
|
2024
Q4 | $79.8M | Buy |
509,459
+71,200
| +16% | +$11.2M | 0.01% | 622 |
|
|
2024
Q3 | $79.8M | Sell |
438,259
-161,886
| -27% | -$29.5M | 0.01% | 618 |
|
|
2024
Q2 | $110M | Sell |
600,145
-58,473
| -9% | -$10.7M | 0.01% | 528 |
|
|
2024
Q1 | $117M | Buy |
658,618
+231,255
| +54% | +$41.1M | 0.01% | 513 |
|
|
2023
Q4 | $53M | Buy |
427,363
+171,157
| +67% | +$21.2M | 0.01% | 693 |
|
|
2023
Q3 | $29.7M | Sell |
256,206
-68,741
| -21% | -$7.97M | ﹤0.01% | 821 |
|
|
2023
Q2 | $38.2M | Buy |
324,947
+314,337
| +2,963% | +$36.9M | 0.01% | 772 |
|
|
2023
Q1 | $850K | Buy |
10,610
+688
| +7% | +$55.1K | ﹤0.01% | 1861 |
|
|
2022
Q4 | $786K | Sell |
9,922
-272
| -3% | -$21.5K | ﹤0.01% | 1902 |
|
|
2022
Q3 | $711K | Buy |
10,194
+3,218
| +46% | +$224K | ﹤0.01% | 1942 |
|
|
2022
Q2 | $458K | Sell |
6,976
-2,497
| -26% | -$164K | ﹤0.01% | 2248 |
|
|
2022
Q1 | $630K | Buy |
9,473
+1,368
| +17% | +$91K | ﹤0.01% | 2232 |
|
|
2021
Q4 | $567K | Buy |
8,105
+3,886
| +92% | +$272K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $220K | Hold |
4,219
| – | – | ﹤0.01% | 2683 |
|
|
2021
Q2 | $287K | Buy |
4,219
+500
| +13% | +$34K | ﹤0.01% | 2603 |
|
|
2021
Q1 | $287K | Buy |
+3,719
| New | +$287K | ﹤0.01% | 2577 |
|
|
2020
Q4 | – | Sell |
-482,899
| Closed | -$20.8M | – | 2697 |
|
|
2020
Q3 | $20.8M | Sell |
482,899
-539,516
| -53% | -$23.2M | ﹤0.01% | 1148 |
|
|
2020
Q2 | $42.3M | Buy |
1,022,415
+129,591
| +15% | +$5.37M | 0.01% | 903 |
|
|
2020
Q1 | $38.6M | Sell |
892,824
-157,761
| -15% | -$6.82M | 0.01% | 867 |
|
|
2019
Q4 | $58.2M | Sell |
1,050,585
-25,173
| -2% | -$1.39M | 0.01% | 864 |
|
|
2019
Q3 | $37.4M | Buy |
1,075,758
+148,679
| +16% | +$5.16M | 0.01% | 965 |
|
|
2019
Q2 | $37.3M | Buy |
927,079
+622,959
| +205% | +$25.1M | 0.01% | 982 |
|
|
2019
Q1 | $10M | Buy |
304,120
+600
| +0.2% | +$19.7K | ﹤0.01% | 1320 |
|
|
2018
Q4 | $6.31M | Buy |
+303,520
| New | +$6.31M | ﹤0.01% | 1380 |
|